Digital Spatial Profiling Demonstrates Profiling of Proteins and 1,000+ mRNAs Across Multiple Regions from FFPE Tissue Sections using Next Generation Sequencing Readout First Customer Data Using Hyb & Seq Single Molecule Sequencing Demonstrates  Potential Utility in Oncology and Infectious Disease SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic […]

Powers Faster Runs and Smaller Sample Batching for High-Throughput Applications In January 2017, Illumina launched the NovaSeq 6000 Sequencing System. With unmatched scalable throughput, tremendous flexibility for a range of applications, and streamlined operation, the NovaSeq 6000 is the most powerful high-throughput Illumina sequencing system to date. It is uniquely positioned to help users discover more […]

Development of new software will improve treatment options for patients Cambridge, United Kingdom and Dublin, Ireland – New software to deliver faster and more accurate diagnoses in genetic epilepsies is the ambition of a ground-breaking partnership between Congenica, a global provider of clinical genomics interpretation software, and FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological […]

UK Science and Industry collaboration successfully shows optical processing technology performing genetic sequence alignment significantly reducing HPC power consumption GLASSHOUGHTON, WEST YORKSHIRE, U.K. and NORWICH, U.K.– Optalysys Ltd. (@Optalysys), a start-up commercialising light-speed optical coprocessors for AI/deep learning, and world-leading genomic research institute The Earlham Institute, EI, (@EarlhamInst), today announced the successful completion of the Genetic […]

Almac Diagnostics selects DNAnexus for NGS-driven adaptive trial design to optimize and de-risk clinical trials, enabling the use of biomarkers in refining participant selection. MOUNTAIN VIEW, Calif. & CRAIGAVON, Northern Ireland–(BUSINESS WIRE)–DNAnexus, the global leader in biomedical informatics and data management, today announced the availability of its Clinical Trial Solution (CTS) which streamlines the use […]

Mountain View, CA—To advance the understanding of cell diversity and how that diversity impacts complex cellular functions including interactions with other cells and molecules, growth, and disease states, Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce the launch of the SMARTer ICELL8 cx […]

NEB® scientists, collaborators and customers to showcase data on new and upcoming NEBNext® technologies, including enzymatic DNA fragmentation, target enrichment, single cell RNA sequencing, and methylation analysis Ipswich, MA — Can an enzyme-based approach reliably and randomly generate DNA fragments for all GC contents and input amounts? How can each step in the next generation sequencing (NGS) library […]

Direct Labeling chemistry provides chromosome arm length maps and improves SV detection resolution down to 500 bp for as little as $500 per genome To be showcased at the AGBT General Meeting this week SAN DIEGO —  Bionano Genomics, the genome mapping company, today announced the global commercial launch of new chemistry for sequence motif […]

Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies demonstrating Horizon’s ability to generate revenues from internally derived IP Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards and […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the “ITC”) has terminated its investigation into whether Oxford Nanopore’s MinION and PromethION devices and associated consumables, reagents, and software infringe one or more claims of U.S. Patent Nos. 9,404,146 and 9,542,527, owned by Pacific Biosciences. The decision by the ITC is based on its […]